Australia Diabetes Care Devices Market Analysis and Forecasts to 2015

Abstract

Australia Diabetes Care Devices Market Analysis and Forecasts to 2015

Summary

GlobalData’s medical device report: “Australia Diabetes Care Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the Australia diabetes care devices market. The report provides market landscape, competitive landscape and market trends information on two market categories – glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.

Scope

- Forecasts & Analysis of the Australia diabetes care devices market to 2015.
- Market segmentation by glucose monitoring and insulin delivery. Glucose monitoring further segmented into blood glucose meters and blood glucose test strips. Insulin delivery further segmented into insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.
- Market Analysis from 2001 to 2008, including new updated 2008 data.
- Analysis of the leading companies and competitive landscape including 2008 company market share analysis.
- Analysis of key diabetes care pipeline products, new technologies and clinical trials.
- Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.
- Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.

Reasons to buy

- Understand what the new growth opportunities are within the Australia diabetes care devices market.
- Develop a clear knowledge & understanding of the Australia diabetes care devices competitor landscape and how this will change to 2015.
- Identify acquisition opportunities across the Australia diabetes care devices market.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

Keywords

australia health structure, diabetes market, glucose monitoring, insulin delivery, pens, pumps, meters, strips, distribution, average price, value, competitive analysis, company share, market share, average price, pipeline products, drivers, restraints, volume, F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Novo Nordisk A/S, Sanofi-Aventis, ARKRAY, Inc., Terumo Corporation, Animas Corporation, Eli Lilly and Company, AiMedics Pty Ltd, Medtronic, Inc., Becton, Dickinson and Company, Smiths Medical, Apex Biotechnology Corp., National Diagnostics Products Pty. Limited.